Objective: To assess the association of gene polymorphisms of angiotensinogen (AGT), the key factor in rennin-angiotensin-aldosterone system (RAAS), with highsensitivity C-reactive protein (hs-CRP) and coronary artery disease (CAD).
| INTRODUC TI ON
Coronary artery disease (CAD) is a common cardiovascular disease, with a high mortality in acute coronary events. Approximately 17 million people die from CAD annually worldwide. 1 CAD presents a series of clinical symptoms characterized by precordial pain caused by coronary artery stenosis, myocardial insufficiency, myocardial anoxia caused by coronary artery lipid deposition, spasm, atherosclerosis, and increased myocardial oxygen consumption. Etiology studies have shown that CAD is a chronic complex disease mediated by multiple genes and interactions between genes and environment, of which organism inflammation reaction may lead to vascular endothelial damage, which plays an important role in the process of atherosclerosis and promotes the onset of CAD. 2 Angiotensinogen (AGT) encodes the precursor of angiotensin (Ang) that is the only known renin substrate. AGT forms Ang II under the action of renin and angiotensin-converting enzyme (ACE). In renin-angiotensin system (RAS), Ang II regulates vasoconstriction, water-electrolyte metabolism, aldosterone biosynthesis, important for angiotasis, cardiac, and vascular remodeling. Binding of Ang II to Ang II type 1 receptor (AT1R) stimulates vascular endothelial cells (VEC) to increase release of chemotactic factor, promote neutrophil aggregation, and induce the onset of atherosclerosis. Ang II also stimulates the growth of vascular smooth muscle cells, increases the proliferation of myocardial cells and intima, increases the activity of sympathetic nerve system, increases the resistance of the coronary artery, and even induces arrhythmia. It also contracts coronary artery, and even rupture the plaque, leading to local thrombosis. 3 Therefore, the relationship between the RAS gene AGT and the pathological process of CAD has obtained wide attention.
C-reactive protein (CRP) is an acute phase inflammatory response protein synthesized in the liver. In homeostatic condition, CRP levels are low, but can increase by 1000 times when infection, trauma, surgery, and other inflammatory events occur for 7-12 days. 4 In prospective studies, early warning effect of high-sensitivity C-reactive protein (hs-CRP) on CAD risk is higher than that of traditional biochemical markers (such as TC, HDL-C, LDL-C, and Lp (a)). Meanwhile, only hs-CRP and TC/HDL-C are independent risk factors 5 in multivariate analysis of other CAD risk factors. Three categories of hs-CRP levels (<1, 1-3 and >3 mg/L) have been used to stratify cardiovascular risk. Because some lipid levels fail to effectively alert coronary artery cases, the use of both TC and hs-CRP will increase the opportunity to predict coronary artery events. 6 In this study, we analyzed the relationship of AGT gene in RAS system and hs-CRP levels with Chinese Han population CAD patients in Zhejiang, Taizhou, China, to provide the basis for molecular prediction of the degree of vascular lesions in CAD patients.
| MATERIAL AND ME THODS

| Patients
This study prospectively recruited the patients who were hospitalized for suspected coronary artery disease and tested by 
| Evaluation of coronary artery stenosis degree
Coronary angiography (CAG) was conducted by at least two experienced clinicians. At least two senior clinicians evaluate CAG and the degree of coronary artery stenosis independently. Then, we used the numbers of lesion vessels and the Gensini Score to quantify the degree of coronary artery stenosis as previously reported. 8
| AGT genotyping
| Blood collection and DNA extraction
The 2 mL of peripheral venous blood was drawn from each patient. Genomic DNA was extracted from peripheral blood leukocytes using DNA Extraction kit according to manufacture's instruction (GK1042; Shanghai Generay Biotech Co., Ltd, Shanghai, China), dissolved with appropriate volume of TE buffer (pH8.0), and were measured by nucleic acid analyzer. Only samples with a ratio of DNA at 1.7-2.0 were used as for polymerase chain reaction (PCR).
| Primer synthesis
Specific primers of five AGT single-nucleotide polymorphisms (SNP), including M235T, G217A, G152A, G-6A, A-20C were designed using Primer Premier 5.0 ( Table 1 ).
| Determination of AGT polymorphism
AGT gene polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphism and confirmed by direct sequencing. Genomic DNA (0.1 μg) was amplified by PCR under the conditions included preheating at 95°C for 2 minutes for initial denaturation, followed by 35 cycles of denaturation at 94°C for 45 seconds, annealing at their own annealing temperature (as per list enclosed) for 45 seconds, and extension for 1 minute at 72°C, with a final extension for 10 minutes at 72°C. PCR products were confirmed using 1.8% agarose gel electrophoresis, ehidium bromide staining ( Figure 1) , and predicted product size as reported previously. 8 
| Statistical analysis
Genetic linkage disequilibrium and haplotype were analyzed by SHEsis software (http://analysis.bio-x.cn/myAnalysis.php). Gene frequency was used to calculate the genotypes and allele frequency of the two groups (Composition ratio, CR), allele frequency = (2* homozygous + heterozygote)/(2*the participants), the comparison of frequency was evaluated by χ 2 test. Means ± SD of quantitative data were calculated and compared by student's t test. Throughout P < 0.05 was considered significant. All calculations were performed using SPSS18.0 statistical package.
| RE SULTS
| Baseline characters and laboratory testing
There were statistically significant differences in gender, age, smoking history, co-morbidities (diabetes, carotid atherosclerosis, lower extremity atherosclerosis), and the levels of hs-CRP, blood glucose and HDL levels ( Table 2 ). However, we did not see statistical difference between CAD and non-CAD patients in alcohol drinking history, hypertension, cerebral infarction, creatinine, serum troponin, triglyceride, total cholesterol, LDL, apolipoprotein A1, apolipoprotein B, or lipoprotein. In CAD patients, the levels of CRP varied significantly depending on the number of branches of coronary artery (1, 2, or ≥3; P = 0.000). There was a trend for positive association of CRP levels with the numbers of coronary artery branches (Table 3) .
Gensini integral was also positively correlated with hs-CRP levels (P = 0.000).
| Genotype and allele distribution frequency analysis
DNA sequencing confirmed the specificity of PCR products for G217A, G152A, G-6A and A-20C site as well as M235T loci (Figure 2 ). 
| Linkage imbalance and haplotype analysis
AGT gene M235T, G217A, G152A, A-20C, and G-6A site were analyzed by SHEsis, linkage imbalance relationship showed that the M235T and G-6A site allelic distribution presented as strong linkage disequilibrium (D′ = 0.897, r 2 = 0.670). Meanwhile, G152A and A-20C site alleles presented as a loose linkage imbalance (D′ = 0.941, r 2 = 0.227; Figure 3 ).
| D ISCUSS I ON
In the current study, we found no differences in the genotype and allele distribution frequency of AGT gene, M235T, G217A, G152A, G-6A, and A-20C site between CAD and non-CAD patients.
However, after adjusted for serum hs-CRP level, the independent risk factor for CAD, we identified M235T and C allele as a risk element and a risk factor, respectively, for CAD.
The human AGT gene is located in the q42. be attributed to population genetic background and race. In addition, in patients that carry the 235T allele, plasma AGT levels were 10%-20% higher than those in non-carriers, with the highest levels of AGT expression in patients with TT genotype. 12 It was speculated that the molecular variation of the AGT gene M235T may affect the expression of AGT and/or Ang II. Besides, G-6A
and A-20C mutations in AGT gene 5 'end can increase the transcription level of AGT gene and increase its gene expression, the mutations at the two sites were linkage imbalance with M235T, indicating that M235T may be only a genetic marker, G-6A and A-20C may be the direct cause of increased plasma AGT levels.
We failed to demonstrate the genotype and allele distribution frequency of AGT gene polymorphisms (M235T, G217A, G152A,
G-6A, and A-20C) between CAD and non-CAD patients, although
it has been 13 reported that AGT gene M235T may be a susceptible factor for myocardial infarction in a Chinese population, which may be related to the difference of the subjects.
CRP is an acute phase response protein can be secreted by liver and cells in atherosclerotic plaques, it is the most widely studied inflammatory marker and is related to the activation of F I G U R E 2 Representative images of polymorphisms for Angiotensinogen (AGT) (M235T, G217A, G152A, G-6A, A-20C), and each arrow indicates a singlenucleotide polymorphism of them circulating monocytes, cytokine release, endothelial dysfunction, smooth muscle cell migration, and extracellular matrix remodeling. 4, 14 CRP is not only an inflammatory marker, but plays a direct regulatory role in the process of atherosclerosis. 15 Consistently, the current study showed a statistically significantly difference in the serum levels of hs-CRP between the CAD and non-CAD groups. Increasingly, studies have shown that the circulating hs-CRP is closely related to coronary artery events, including myocardial infarction, stroke, lower extremity arterial disease, sudden cardiac arrest, and other events. 16 CRP as independent predictor has been considered to be more valuable than LDL. In previous study, it has been already proved that there was a good correlation between hs-CRP levels and the severity of coronary artery anatomical lesion, 17 which is consistent with the correlation we found between the coronary score and the hs-CRP level in CAD patients (r = 0.358, P = 0.000). Interestingly, the interaction of AngII and CRP in the vascular wall has been confirmed. AngII induced CRP production by vascular smooth muscle cells via the AT1 receptor pathway accompanying by the activation of MAPK signaling pathway. 3 AngII stimulated human aortic endothelial cells (hAECs) and promoted the expression of CRP mRNA and protein. 18 In the current study, we further found following stratification of patients according to hs-CRP levels, the distribution frequency of allele M235T was statistically different among the groups. The C allele frequency distribution in CRP < 1 mg/L and ≥1 mg/L groups was statistically significant difference. Combined with the previous reports, our study suggests that M235T may confer susceptibility to CAD via AngII-CRP related pathway. The distribution was analyzed by the R × C chi-square test.
| CON CLUS ION
In CAD patients, the severity of vascular lesions was positively associated with hs-CRP levels. Despite no difference in AGT M235T, G152A, G-6A, A-20C polymorphism between CAD and non-CAD patients,
AGT gene M235T was associated with high hs-CRP levels. Thus, our study suggests that M235T may confer susceptibility to CAD.
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